Analytical and clinical performance of the vitros® immunodiagnostic products BRAHMS PCT assay on the vitros immunodiagnostic systems

被引：0
|
作者：
Ogbonna, G. [1 ]
Alvey, S. [1 ]
Hryhorenko, E. [1 ]
Parsells, J. [1 ]
Phonethepswath, S. [1 ]
Smith, B. [1 ]
机构：
[1] Ortho Clin Diagnost, Rochester, NY USA
来源：
CLINICA CHIMICA ACTA | 2022年 / 530卷
关键词：
D O I：
10.1016/j.cca.2022.04.024
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
M142
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [11] Comparison of the performance of MicroWell™ assays on the VITROS® 5600 Integrated System and the VITROS® 3600 Immunodiagnostic System versus the VITROS® ECiQ Immunodiagnostic System
    Sullivan, S. S.
    Warren, K.
    Kilmartin, P.
    Schroff, A.
    Sawyer, B.
    Ricotta, M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A205 - A205
  • [12] Clinical evaluation of the Vitros® PSA on the Vitros® ECi immunodiagnostic system.
    Ryerson, CC
    Kearney, F
    Brunwin, DM
    Moon, C
    Hughes, R
    Wilkinson, E
    Budden, J
    Fenton, S
    Dubbs, S
    CLINICAL CHEMISTRY, 1999, 45 (06) : A116 - A116
  • [13] Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays
    De Keukeleire, Steven
    Wauters, Annick
    Luyts, Dave
    Chandler, Candice
    Piqueur, Marian
    CLINICAL BIOCHEMISTRY, 2014, 47 (13-14) : 1323 - 1325
  • [14] Clinical Performance of the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Antibody Assay
    Contestable, Paul
    Noeson, Charles
    Colvin, Michael
    Novick, Bethany
    Clark, Sierra
    Hosimer, Philip
    TRANSFUSION, 2020, 60 : 285A - 286A
  • [15] Performance evaluation of the VITROS® TSH3*assay on the VITROS® 5600/XT7600 integrated and VITROS® 3600 and ECI/ECIQ immunodiagnostic systems
    Thomas, C.
    Stevens, R.
    West, L.
    Oliver, E.
    Pang, J.
    Griffiths, H.
    CLINICA CHIMICA ACTA, 2019, 493 : S321 - S322
  • [16] Multicenter evaluation of the Vitros® Immunodiagnostic products HBsAg reagent pack and calibrator (Vitros HBsAg assay) and the Vitros Immunodiagnostic products HBsAg confirmatory kit (Vitros HBsAg confirmatory kit) in patients with signs and symptoms of hepatitis or at risk for viral hepatitis.
    Calcagno, JV
    Schiff, E
    Latimer, MJ
    Geiger, D
    Attar, B
    Gitnick, G
    Gorlin, JB
    Page, E
    Cummins, T
    CLINICAL CHEMISTRY, 2001, 47 (06) : A99 - A99
  • [17] Performance Evaluation of anti-HCV Assay on VITROS® 3600 Immunodiagnostic System
    Giacherio, D.
    VasBinder, E.
    Forbing, K.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A151 - A151
  • [18] EVALUATION OF THE VITROS® 3600 IMMUNODIAGNOSTIC SYSTEM
    Buehling, F.
    Kanter, G.
    Sonntag, O.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A47 - A48
  • [19] An Evaluation of Performance of the VITROS® Immunodiagnostic Products Anti-Sars-Cov-2 IgG Quantitative Assay
    Contestable, Paul
    Hirsch, Brett
    Gardner, Amanda
    TRANSFUSION, 2021, 61 : 174A - 175A
  • [20] T225 Performance evaluation of the VITROS® hs Troponin I assay* on the VITROS® ECi/ECiQ and 3600 immunodiagnostic and VITROS® 5600/XT 7600 integrated systems
    Jackson, S.
    Oliver, E.
    Smith, K.
    Michael, K.
    Cleary, M.
    CLINICA CHIMICA ACTA, 2019, 493 : S198 - S198
12345